Red Wine Reduces Heart Disease? - - Chromatography Online
Red Wine Reduces Heart Disease?

E-Separation Solutions

Malvidin, a polyphenol found in red wine, has been presented as a potential candidate for the reduction of heart disease. Published in the Journal of Nutritional Biochemistry (1), the study presents a case for the use of malvidin as a nutraceutical; a food supplement with health-promoting benefits.

Polyphenols are abundant in a range of foods and are responsible for colour and taste properties. The health-promoting properties of certain polyphenols have been characterized in great detail, leading to the commercial production of resveratrol, which is sold as a food supplement. But, until now, malvidin has remained previously uncharacterized.

The team used high performance liquid chromatography (HPLC) analysis to show relatively high levels of malvidin in the skin and juice of red grapes used in wine production. Malvidin-rich extracts were then administered to hearts in vitro, showing a demonstrated increase in heartbeat strength and coronary relaxation, and therefore blood flow and oxygen supply to the heart muscle.

The authors suggested that malvidin could be a potential candidate for the treatment of myocardial ischemia, a condition where oxygen supply to the heart muscle is significantly reduced. However, the concentration of malvidin within the administered samples was relatively high, with a relatively high selectivity for the compound. The study paves the way for future investigation to pinpoint the polyphenol that promotes the most positive activity and the most favourable quantity required for a healthy heart.


1. A.M Quintieri, N. Baldino, E. Filice, L. Seta, A. Vitetti, B. Tota, B. De Cindio, M.C Cerra and T. Angelone, Journal of Nutritional Biochemistry, DOI: 10.1016/j.jnutbio.2012.09.006 (20)


blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:



Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration

Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies

MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis

LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase

More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>

Source: E-Separation Solutions,
Click here